Trials have been conducted in Europe, Canada and Australia with recruits numbering in the hundreds. They have been structured on the understanding that VitroGro is a "device" with the expectation that success would lead to the CE mark of approval. All recruits to trials were people with "hard to heal" wounds - ie unresponsive to conventional treatments. The trials met with much success - not sure where to look for formal results as some of this goes back several years. If website does not satisfy your curiosity - suggest a call to TIS management.
TIS Price at posting:
29.0¢ Sentiment: Buy Disclosure: Held